Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Top Five Pharma Stories Of 2023

Jan 24 2024

• By Kevin Grogan

Number 5 — • Source: Shutterstock

Related Content

GSK Seeks To Prevent Pfizer From Selling Its Rival RSV Vaccine In the US

Aug 03 2023

Medicare Inflation Penalty Hits 64 Products In First Year

Dec 22 2023

Sanofi/AstraZeneca Resolving Beyfortus Shortage By Reallocating Southern Hemisphere Supply

Dec 21 2023

The FLOW Of Novo Nordisk's Semaglutide Success Rolls Into Kidney Disease

Oct 11 2023

SELECT: Novo Nordisk Comes Roaring Back

Aug 08 2023

Sickle Cell Drug Development Gains Momentum Across Disease Spectrum

Dec 15 2023

A Stellar Launch For RSV Vaccine Arexvy Lifts GSK

Nov 01 2023

With Seagen Integration In Sight, Pfizer Reorganizes Commercial And R&D

Dec 13 2023

US FTC Ruffles Pharma’s Feathers Again

Dec 12 2023

Vertex/CRISPR Nab First-Ever Gene Editing FDA Nod, Overshadow Bluebird’s Same-Day Win

Dec 09 2023

Trial Recruitment Closes On Novo’s Next Big Semaglutide Bet: Alzheimer’s Disease

Jul 19 2023

Amgen’s FTC Settlement To Allow $27.8bn Horizon Deal Closure Sets New M&A Precedent

Sep 01 2023

Novo Mulls What To Do With Wegovy Windfall

Oct 04 2023

Big Rebates Already A Big Factor For Drugs On Medicare Negotiation List

Aug 29 2023

Abrysvo Launch A Bright Spot For Pfizer In A Third Quarter Reset

Oct 31 2023

Industry CEOs Talk Drug Pricing, Value And The IRA

Nov 14 2023

Moderna Peers Into Post-Pandemic Future For Respiratory Vaccines

Apr 11 2023

Pharma vs The IRA — Industry Leaders React To Merck Lawsuit

Jun 07 2023

Novo Nordisk Has Plans For Semaglutide In NASH Too

Nov 15 2023

Vertex Achieves Gene-Editing Milestone With First Ever CRISPR Therapy Approval

Nov 16 2023

Related Companies

Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics AG

Genetix Biotherapeutics

Merck & Co., Inc.

Bristol Myers Squibb Company

Astellas Pharma, Inc.

Johnson & Johnson

Boehringer Ingelheim GmbH

Eli Lilly and Company

AstraZeneca PLC

Novartis AG

Amgen, Inc.

Horizon Therapeutics plc

Seagen Inc.

Maze Therapeutics, Inc.

GSK plc

Moderna, Inc.

Additional Topics

Approvals Companies Deals Strategy Regulation Market Intelligence BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window